Tokenization's Real Test Is Collateral, Not Returns

Tokenization has crossed from technical demonstration to business-case scrutiny, and no group is demanding more from that business case than insurers, as Calum McNiven, head of counterparty and derivative management, investment execution, argues in Insurance AUM Journal. For ALM-heavy institutions and insurers, the clearest near-term payoff lies in collateral efficiency rather than return enhancement or new asset classes: faster settlement, more mobile collateral, responsive liquidity sequencing, and less reliance on cash transformation.

At its simplest, tokenization represents ownership of a traditional financial asset—a bond, a fund, or a cash instrument—as a digital token on a distributed ledger. The wrapper's value lies in allowing that token to be recognized, controlled, valued, transferred, and enforced as collateral under the same governance framework as conventional assets.

"This is increasingly a collateral and asset and liability management (ALM) story rather than a technology story," McNiven writes.

The economic impact of tokenized collateral is most valuable when markets are under stress, the moment margin pressures rise and insurers must choose between preserving eligible assets and disrupting strategic portfolios. If high-quality liquid assets and cash equivalents can be mobilized faster and with less operational friction, the value is quantifiable; if they cannot be posted at a CCP, under a legal framework, or through a triparty agent's operating model, the token is just a certificate.

Tokenized government bonds, money-market funds, and select credit instruments are already live or being piloted on institutional platforms. Their relevance to ALM budgets, however, depends less on the token than on the operating model around it—whether the asset can be recognized, controlled, valued, transferred, enforced, and reported under the same governance framework as existing collateral.

The governance test runs through a wide ecosystem—regulated asset issuers, custodians and triparty agents, trading banks and counterparties, CCPs and market infrastructures, legal and documentation specialists, and digital-asset providers capable of issuance, transfer, and control—making the constraint legal and operational rather than technical.

Tokenization will deliver value to insurers to the extent that it is owned by the collateral desk rather than the innovation office. The article's emphasis on operating models, legal frameworks, and CCP readiness amounts to a procurement decision: insurers do not need to build tokenization platforms, only to demand that their existing custodians, triparty agents, CCPs, and legal counterparties accept tokenized assets as collateral and to test those assets in stress scenarios where the economics matter.

The firms that capture the benefit will be the first to wire tokenized assets into margin calls, liquidity buffers, and collateral optimization workflows and to prove to counterparties that those assets can be enforced, because the constraint has moved from creating tokens to getting them accepted.

McNiven sets no timeline for mainstream adoption, and none is needed; the debate has moved from technical feasibility to legal and operational readiness, and the next cycle's competition will be over which operating model can support institutional scale.

The insurers to watch are the ones quietly testing whether a CCP will accept tokenized government bonds in a live margin call, because that live test is where the collateral story will be won.